Welcome to Targeting Ebola International Congress 2015

logo Task force

On behalf of the Targeting Infectious Diseases Committee, the Institut Pasteur, the COPED (Committee for Developping Countries) and the Task Force for Ebola in France, it is our pleasure to announce the organization of the 1st International Congress on Targeting Ebola Virus which will be held on May 28-29, 2015 in Paris, France

The World Health Organization (WHO) was notified on March 23, 2014, of an outbreak of EVD in Guinea. The disease soon spread to the bordering countries of Liberia and Sierra Leone, which are the most severely affected countries. On August 8, 2014, the epidemic was declared a “public health emergency of international concern” (WHO Ebola Response Team, NEJM 2014, 371, 1481). Suspected cases of EVD have since been reported in seven affected countries (Guinea, Liberia, Nigeria, Senegal, Sierra Leone, Spain, and the United States of America). Unprecedented in scale and geographical distribution since the identification of Ebola in 1976, the current epidemic has an apparent overall case-fatality ratio of about 70%; but it is suspected that many more cases have gone unrecorded. The WHO reported on October 14, 2014 that the number of new Ebola cases could reach 10,000 per week by December 2014. On February 2015, more than 8.900 deaths and 22.495 cases had been reported in Sierra Leone, Liberia and Guinea, according to the WHO.

Targeting Ebola 2015 Challenges

While there is no licensed treatment yet available for EVD, a range of blood, immunological and drug therapies are under development and two potential vaccine candidates are undergoing evaluation, according to the WHO.

Targeting Ebola 2015 will provide a unique and cutting edge conference to discuss the recent advances, strategies and challenges of all Ebola fields. The keynote lectures given by leading scientists, as well as poster presentations covering various aspects of Ebola infection.

During Ebola 2015 a Practical approach will address and discuss different strategies and challenges (short and long term) across the entire innovation cycle. We will discuss about the vaccine candidates available and the ability to roll out clinical trial vaccination programmes in EU / Africa, and how to conduct studies in areas where Ebola virus disease is endemic. We will highlight how a rapid diagnostics can detect EVD at acceptable costs and with very high sensitivity and specificity. We will invite academics and industrials to discuss strategies to treat Ebola infection by innovative drugs, Immunotherapy and others. We will take en consideration the Ethical and political issues of this strategic problem.

The topics of the Ebola 2015 cover many sessions:

  • Ebola virus disease: where are we now and where do we go?
  • The Hemoragic Fever Viruses: Recent Advances
  • Virus-Host Interactions: State-of-the-Art
  • Epidemiology: The Current Situation
  • The Diagnostic Tools
  • Treatment & Vaccines
  • Operational Researches: Present & Future 

A discussion will be held between speakers, scientifists, industry sector and ethical and political organisations.

We hope that you will join us for this dynamic and strategic program and look forward to welcoming you in Paris.

Pr Christian Bréchot - Pr Jean-François Delfraissy - Pr François Gros
Gérard Orth - Pr Felix Rey

Dr Reiko Suzuki - Paris Ebola 2015

On behalf of TID Committee

signature Rieko Suzuki